scholarly journals Podoplanin discriminates distinct stromal cell populations and a novel progenitor subset in the liver

2016 ◽  
Vol 310 (1) ◽  
pp. G1-G12 ◽  
Author(s):  
Christoph Eckert ◽  
Yong Ook Kim ◽  
Henrike Julich ◽  
Eva-Carina Heier ◽  
Niklas Klein ◽  
...  

Podoplanin/gp38+ stromal cells present in lymphoid organs play a central role in the formation and reorganization of the extracellular matrix and in the functional regulation of immune responses. Gp38+ cells are present during embryogenesis and in human livers of primary biliary cirrhosis. Since little is known about their function, we studied gp38+ cells during chronic liver inflammation in models of biliary and parenchymal liver fibrosis and steatohepatitis. Gp38+ cells were analyzed using flow cytometry and confocal microscopy, and the expression of their steady state and inflammation-associated genes was evaluated from healthy and inflamed livers. Gp38+ cells significantly expanded in all three models of liver injury and returned to baseline levels during regression of inflammation. Based on CD133 and gp38 expression in the CD45−CD31−Asgpr1− liver cell fraction, numerous subsets could be identified that were negative for CD133 (gp38hiCD133−, gp38lowCD133−, and gp38−CD133−). Moreover, among the CD133+ cells, previously identified as progenitor population in injured liver, two subpopulations could be distinguished based on their gp38 expression (gp38−CD133+ and CD133+gp38+). Importantly, the distribution of the identified subsets in inflammation illustrated injury-specific changes. Moreover, the gp38+CD133+ cells exhibited liver progenitor cell characteristics similar to the gp38−CD133+ population, thus representing a novel subset within the classical progenitor cell niche. Additionally, these cells expressed distinct sets of inflammatory genes during liver injury. Our study illuminates a novel classification of the stromal/progenitor cell compartment in the liver and pinpoints a hitherto unrecognized injury-related alteration in progenitor subset composition in chronic liver inflammation and fibrosis.

Hepatology ◽  
2009 ◽  
Vol 49 (5) ◽  
pp. 1625-1635 ◽  
Author(s):  
Noémi K. M. Van Hul ◽  
Jorge Abarca-Quinones ◽  
Christine Sempoux ◽  
Yves Horsmans ◽  
Isabelle A. Leclercq

2016 ◽  
Vol 186 (7) ◽  
pp. 1762-1774 ◽  
Author(s):  
Julia Köhn-Gaone ◽  
Benjamin J. Dwyer ◽  
Candice A. Grzelak ◽  
Gregory Miller ◽  
Nicholas A. Shackel ◽  
...  

2010 ◽  
Vol 53 (3) ◽  
pp. 500-507 ◽  
Author(s):  
Cornelia S. Viebahn ◽  
Volker Benseler ◽  
Lauren E. Holz ◽  
Caryn L. Elsegood ◽  
Michelle Vo ◽  
...  

2021 ◽  
Vol 22 (21) ◽  
pp. 11575
Author(s):  
Ludmilla Unrau ◽  
Jessica Endig ◽  
Diane Goltz ◽  
Paulina Sprezyna ◽  
Hanna Ulrich ◽  
...  

Myeloid cells play an essential role in the maintenance of liver homeostasis, as well as the initiation and termination of innate and adaptive immune responses. In chronic hepatic inflammation, the production of transforming growth factor beta (TGF-β) is pivotal for scarring and fibrosis induction and progression. TGF-β signalling is tightly regulated via the Smad protein family. Smad7 acts as an inhibitor of the TGF-β-signalling pathway, rendering cells that express high levels of it resistant to TGF-β-dependent signal transduction. In hepatocytes, the absence of Smad7 promotes liver fibrosis. Here, we examine whether Smad7 expression in myeloid cells affects the extent of liver inflammation, injury and fibrosis induction during chronic liver inflammation. Using the well-established model of chronic carbon tetrachloride (CCl4)-mediated liver injury, we investigated the role of Smad7 in myeloid cells in LysM-Cre Smadfl/fl mice that harbour a myeloid-specific knock-down of Smad7. We found that the chronic application of CCl4 induces severe liver injury, with elevated serum alanine transaminase (ALT)/aspartate transaminase (AST) levels, centrilobular and periportal necrosis and immune-cell infiltration. However, the myeloid-specific knock-down of Smad7 did not influence these and other parameters in the CCl4-treated animals. In summary, our results suggest that, during long-term application of CCl4, Smad7 expression in myeloid cells and its potential effects on the TGF-β-signalling pathway are dispensable for regulating the extent of chronic liver injury and inflammation.


Sign in / Sign up

Export Citation Format

Share Document